Top brokers name 3 ASX shares to buy next week

Brokers gave the thumbs up to these ASX shares last week. Here's why they are bullish on them…

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here's why brokers think investors ought to buy them next week:

Three people in a corporate office pour over a tablet, ready to invest.

Image source: Getty Images

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Goldman Sachs, its analysts have retained their buy rating on this gaming technology company's shares with an improved price target of $45.70. Goldman has been looking at Aristocrat's digital portfolio and Anaxi iGaming business and is very positive on their long-term outlooks. In respect to the latter, the broker sees Anaxi as a key growth opportunity and feels the potential upside is being underestimated by the market. The Aristocrat share price ended the week at $37.16.

IGO Ltd (ASX: IGO)

Another note out of Goldman Sachs reveals that its analysts have upgraded this battery materials miner's shares to a buy rating with a $13.90 price target. Although the broker still sees near term earnings downside as lithium price declines flow into realised pricing and capex increases likely flow through consensus estimates, it still sees emerging fundamental value based on its lithium price forecasts. The IGO share price was fetching $13.43 at the end of the week.

NextDC Ltd (ASX: NXT)

Analysts at Morgans have retained their add rating on this data centre operator's shares with an improved price target of $13.50. This follows news of a major increase to its contracted utilisation. Morgans was impressed with the news and appears to believe that Microsoft could be its big new customer. It highlights that the tech giant recently canned plans to develop its own data centre and needs capacity to support the exponential demand for ChatGPT, which runs on its Azure Cloud Infrastructure. The NextDC share price was trading at $12.15 at Friday's close.

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Four young friends on a road trip smile and laugh as they sit on roof of their car.
Broker Notes

4 ASX shares tipped by brokers to return 18% to 96%

Brokers have a buy or strong buy rating on all these ASX shares.

Read more »

Three friends walking together and enjoying free time.
Broker Notes

3 ASX shares tipped to fly 109% to 322% higher

Do you own any of these ASX shares in your portfolio?

Read more »

An investor wearing a dressing gown and holding a cup of coffee in a yellow mug gives a satisfied smile.
Broker Notes

3 ASX shares to buy amid a volatile market: experts

Experts say there are buying opportunities amid today's turbulent trading conditions.

Read more »

Two men and a woman sitting in a subway train side by side, reading newspapers.
Broker Notes

Buy, hold, sell: New Hope, Cleanaway Waste Management, NextDC shares

Let's check out some new ratings on these ASX 200 shares today.

Read more »

Man using his device in an airport.
Broker Notes

Top broker says this ASX stock could rise 115%

Big returns could be on offer here according to Bell Potter.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Goodman, Wesfarmers, BHP shares

Here's what Steven Springford from Catapult Wealth thinks of these 3 ASX 200 heavyweights.

Read more »

Mining vehicle at a mine site.
Broker Notes

2 ASX mining companies tipped to jump 52% and 87%

These two companies are primed for growth, brokers say.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

This ASX health technology company could more than double in value: Broker

A major new recruit was a coup for this company.

Read more »